Johnson and Johnson experienced year-on-year growth in 2011, according to the company's full-year financial report.
The health and personal care company's annual sales total came to $65 billion (41.71 million pounds), up by 5.6 percent compared to 2010, with international growth more than offsetting a small drop in US performance.
Its medical device and diagnostics division represented its biggest earner and most significant driver of growth, while its consumer products division also saw improvement.
Top-selling over-the-counter products included its baby care range, Neutrogena skincare offerings and Listerine antiseptic mouthwash, with recently launched pharmaceutical therapies also contributing significantly.
William Weldon, chairman and chief executive officer, said: "Our talented people are focused on bringing meaningful innovations to patients and customers to address significant unmet needs, positioning us well to deliver sustainable leadership and profitable growth in healthcare."
This marks a successful conclusion to Johnson and Johnson's 125th year in business, having originally been founded in 1886.
The health and personal care company's annual sales total came to $65 billion (41.71 million pounds), up by 5.6 percent compared to 2010, with international growth more than offsetting a small drop in US performance.
Its medical device and diagnostics division represented its biggest earner and most significant driver of growth, while its consumer products division also saw improvement.
Top-selling over-the-counter products included its baby care range, Neutrogena skincare offerings and Listerine antiseptic mouthwash, with recently launched pharmaceutical therapies also contributing significantly.
William Weldon, chairman and chief executive officer, said: "Our talented people are focused on bringing meaningful innovations to patients and customers to address significant unmet needs, positioning us well to deliver sustainable leadership and profitable growth in healthcare."
This marks a successful conclusion to Johnson and Johnson's 125th year in business, having originally been founded in 1886.